FR2088218A1 - Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states - Google Patents
Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic statesInfo
- Publication number
- FR2088218A1 FR2088218A1 FR7019650A FR7019650A FR2088218A1 FR 2088218 A1 FR2088218 A1 FR 2088218A1 FR 7019650 A FR7019650 A FR 7019650A FR 7019650 A FR7019650 A FR 7019650A FR 2088218 A1 FR2088218 A1 FR 2088218A1
- Authority
- FR
- France
- Prior art keywords
- treatment
- nephropathic
- compsns
- lactulose
- acidosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compsns. contg. lactulose (I) and Cytochrome C (II) or hematoporphyrin are active in the treatment of nephropathic acidosis auto-toxic conditions such as diabetes. They also aid medicaments having a vitamin P activity in the treatment of atherosclerosis. The dosage is 0.050-0.070 g (I), 1-12 times daily, administered orally or parenterally. Typically, tablets were prepd. contg. 0.070 g (I), 2 mg (II), and 0.10 g. alpha-chymotripsin, together with conventional excipients.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7019650A FR2088218A1 (en) | 1970-05-29 | 1970-05-29 | Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7019650A FR2088218A1 (en) | 1970-05-29 | 1970-05-29 | Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2088218A1 true FR2088218A1 (en) | 1972-01-07 |
FR2088218B1 FR2088218B1 (en) | 1973-08-10 |
Family
ID=9056325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7019650A Granted FR2088218A1 (en) | 1970-05-29 | 1970-05-29 | Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2088218A1 (en) |
-
1970
- 1970-05-29 FR FR7019650A patent/FR2088218A1/en active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2088218B1 (en) | 1973-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES352030A1 (en) | Urate oxidase and process for the production thereof | |
GB1380171A (en) | Medicinal tablets | |
EP0302714A3 (en) | Pharmaceutical composition for treatment of bone-wasting diseases | |
FR2088218A1 (en) | Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states | |
DE3883208D1 (en) | AGENTS FOR TREATING KERATOSIS. | |
FR2155927A1 (en) | 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity | |
GB950162A (en) | Medicines for the treatment of hepatic disorders | |
Viukari et al. | Effect of methyldopa on tardive dyskinesia in psychogeriatric patients. | |
GB911482A (en) | Pharmaceutical tablets comprising a synergistic combination including salts of ยช--phenoxyethyl penicillin | |
GB1437138A (en) | Method of increasing sexual potency | |
GB1118606A (en) | Compositions for the treatment of haemorrhoids | |
GB976096A (en) | Pharmaceutical compositions | |
Misra | A comparative study of tinidazole and metronidazole as a single daily dose for three days in symptomatic intestinal amoebiasis | |
GB1375806A (en) | ||
SU1273109A1 (en) | Method of treatment of exema and exematized mycosis of foot | |
ES383340A1 (en) | P-(acetoacetamidoalkyl)benzenesulfonamide derivatives | |
IE36780B1 (en) | New pharmaceutical preparations | |
FR2154506A1 (en) | Medicaments contg biotin - as hypoglycaemic agents | |
SU315388A1 (en) | Medicine | |
FR2092649A1 (en) | Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid | |
GB1327465A (en) | Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase | |
FR2152408A1 (en) | Haemorrhoids treatment - using pomegranate peel suspension | |
GB1379959A (en) | Pyrrolidino hydroxy-pentanes | |
FR2260995A1 (en) | Benzimidazole-contg. medicaments - for treating non-malignant gastroduodenal disorders, esp. ulcers and hypersecretion | |
GB1305179A (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |